Octreotide
Octreotide
Definition
A synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone.
Also known as D-Phenylalanyl-L-cysteinyl-L-phenyl-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2->7)-Disulfide, D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol Cyclic (2->7)-Disulfide, D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hyroxymethyl)propyl]-L-cysteinamide, Cyclic (2->7)-disulfide, OCTREOTIDE, SMS 201 995, SMS 201995, SMS-201-995, SMS201995 — per NCIT
Also identified as
- ATC H01CB per NCIT
- NCIT NCIT:C711 per NCIT
Indications
| Disease | Relation | Source |
|---|---|---|
| Acromegaly | may treat | MEDRT · Public domain (U.S. Government work) |
| Adenoma | may treat | MEDRT · Public domain (U.S. Government work) |
| Diarrheal disease | may treat | MEDRT · Public domain (U.S. Government work) |
| Pancreatic neoplasm | may treat | MEDRT · Public domain (U.S. Government work) |